Clinical Trials Directory

Trials / Completed

CompletedNCT01415583

Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
314 (actual)
Sponsor
Massachusetts Eye and Ear Infirmary · Academic / Other
Sex
All
Age
3 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Tonsillectomy (removal of the tonsils) is a very common surgery in children. Bleeding after tonsillectomy is one of the risks of this surgery and can be more dangerous in children since they have less blood volume than adults. In order to improve recovery after tonsillectomy, steroids (medication that is a strong anti-inflammatory) are often given during the surgery. Recently, a study showed steroids given at the time of tonsillectomy increase the risk of bleeding significantly over children who did not receive steroids. This finding has raised concerns in the Ear, Nose, and Throat (ENT) community since most ENT's use steroids during tonsillectomy in children. The investigators look to explore this question further. To answer the question of whether perioperative steroid administration significantly affects the rate of post-tonsillectomy bleeding, the investigators propose to test the following hypotheses in a prospective, randomized, blinded placebo-controlled trial: dexamethasone does not cause an increase in post-operative bleeding rate in tonsillectomy.

Detailed description

Detailed description is entered above

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone0.5mg/kg (max dose 20mg)

Timeline

Start date
2010-07-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2011-08-12
Last updated
2017-07-12
Results posted
2017-07-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01415583. Inclusion in this directory is not an endorsement.